CN Patent
CN102438602B — 改进的干燥粉末药物输送系统
Assigned to Mannkind Corp · Expires 2016-04-13 · 10y expired
What this patent protects
本发明公开了一种肺部药物输送系统,其包括呼吸驱动的干燥粉末吸入器和药筒,用于输送干燥粉末制剂。所述吸入器和药筒可被提供药物输送制剂和活性成分用于治疗内分泌疾病(例如糖尿病和/或肥胖),所述药物输送制剂包括例如二酮哌嗪,所述活性成分包括肽类和蛋白质,诸如胰岛素和胰高血糖素样肽1。
USPTO Abstract
本发明公开了一种肺部药物输送系统,其包括呼吸驱动的干燥粉末吸入器和药筒,用于输送干燥粉末制剂。所述吸入器和药筒可被提供药物输送制剂和活性成分用于治疗内分泌疾病(例如糖尿病和/或肥胖),所述药物输送制剂包括例如二酮哌嗪,所述活性成分包括肽类和蛋白质,诸如胰岛素和胰高血糖素样肽1。
Drugs covered by this patent
- Remodulin (TREPROSTINIL) · United Therap
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.